Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, ANEB-001, is currently in phase two of trial. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.